about
ErbB polymorphisms: insights and implications for response to targeted cancer therapeuticsInsights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer.Computerized tomography based tumor-thickness measurement is useful to predict postoperative pathological tumor thickness in oral tongue squamous cell carcinomaMerkel cell carcinoma of the head and neck: a single institutional experience.A survey on pulmonary screening practices among otolaryngology-head & neck surgeons across Canada in the post treatment surveillance of head and neck squamous cell carcinoma.Clinical parameters predicting development of pulmonary malignancies in patients treated for head and neck squamous cell carcinoma.Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer.Merkel cell carcinoma of the head and neck: poorer prognosis than non-head and neck sites.Detection of Helicobacter pylori in patients with head and neck cancer: Results from a prospective comparative study combining serology, polymerase chain reaction, and rapid urease test.Virtual anthropology: a comparison between the performance of conventional X-ray and MDCT in investigating the trabecular structure of long bones.Congenital pharyngeal webs: Treatment of a rare clinical entity by endoscopic CO2 laser approach.Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer.[Percutaneous embolization and ultrasound scissors for removal of a carotid body tumor].Early Timing of Thyroidectomy for Hyperthyroidism in Graves' Disease Improves Biochemical Recovery.Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinomaOutcome in squamous cell carcinoma of the nasal vestibule: a single center experiencePreoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma
P50
Q28084565-CB970658-D12E-4964-A706-A4AF288CAEE2Q34452105-332FBEDC-CD48-4943-908B-2BD73611D0E0Q36286946-95C1FFBC-8F21-4421-80C5-97095929FA42Q36567288-50C591B8-241A-4104-9AAE-D24AF9C8416FQ38343447-C99A407B-903C-45DE-A78C-0487351A0AACQ38619478-67C3D48F-9852-4FA9-8D12-DC781CC381E2Q39106373-8131166A-28FE-48E8-9A4B-07675C9E9A8FQ40910748-CF89406E-5A27-4D4E-A969-4B330C68A348Q41592223-E8A72556-1CB2-48A8-9BDD-4CC4F15C03DEQ46584709-8B0808E6-D089-44D5-AF86-3B20787CC5CEQ47377781-E7C51A33-2C25-47BA-9612-4263E358AB41Q47716257-008DEA4F-866E-4E7D-9283-A67A9FAC0767Q50239782-743A0800-EADF-4435-B1C1-567067FF6221Q50543929-BD548778-1F95-4D04-A66B-BEEE084261F1Q86079216-86564A7C-F508-4B23-81C6-0C02C0A254B2Q88018769-E96C463B-A392-420F-9696-46B08DEFCA58Q90607610-6F172FBE-3AB8-4AEB-B5D7-8B043F49C893
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Grégoire Morand
@en
Grégoire Morand
@nl
type
label
Grégoire Morand
@en
Grégoire Morand
@nl
prefLabel
Grégoire Morand
@en
Grégoire Morand
@nl
P31
P496
0000-0001-9575-0389